BioSpace News Archive

AB Science S.A. provides an update on the schedule for the evaluation by the Committee for Medicinal Products for Human Use of the European Medicines Agency and by Health Canada of its applications for conditional approval of masitinib in the treatment of amyotrophic lateral sclerosis.

GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) (“GHG” or the “Company”) is pleased to announce that it has completed its contractual obligations relating to the first stage of the binding Letter of Intent (“LOI”)

Merck, known as MSD outside of the United States and Canada, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the third consecutive year, ranking No. 1 in the pharmaceutical industry and advancing 38 spots in the overall rankings from last year-from No. 67 overall in 2022 to No. 29 overall in 2023.

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Institut Pasteur Korea announced that they have jointly developed new lead compounds effective in treating resistant tuberculosis (TB).

The American Urological Association announced the newest members of the 2023 AUA Leadership Program.

QUANTRO Therapeutics, an innovative drug discovery company focused on developing novel targeted therapeutics interfering with disease-causing transcriptional programs in cancer, today announced the appointment of Dr. Michael Bauer as Chief Executive Officer (CEO), effective May 1, 2023.